Fengfeng Xue

Dr. Fengfeng Xue


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Nano Today
Verified
Journal Article
Closed access
QTQiwei Tian
Qiwei Tian
FXFengfeng Xue
Fengfeng Xue
YWYurui Wang
Yurui Wang
YCYuying Cheng
Yuying Cheng
LALu An
Lu An
GHGang Huang
Gang Huang

19 October 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XLXiaomin Li
Xiaomin Li
JWJunyi Wang
Junyi Wang
FXFengfeng Xue
Fengfeng Xue
YWYichen Wu
Yichen Wu
HXHualong Xu
Hualong Xu
QLQiaowei Li
Qiaowei Li

17 February 2022 in Biomaterials
Verified
Journal Article
Closed access
YGYu-Xiang Ge
Yu-Xiang Ge
TZTai-Wei Zhang
Tai-Wei Zhang
LZLei Zhou
Lei Zhou
WDWang Ding
Wang Ding
HLHai-Feng Liang
Hai-Feng Liang
LJLibo Jiang
Libo Jiang

26 July 2022 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YCYuying Cheng
Yuying Cheng
HBHaiji Bo
Haiji Bo
RQRuomeng Qin
Ruomeng Qin
FCFulai Chen
Fulai Chen
FXFengfeng Xue
Fengfeng Xue
QTQiwei Tian
Qiwei Tian
Background: Endogenous hydrogen sulfide (H2S)-responsive theranostic agents have attracted extensive attention due to their specificity for colon cancer. However, the development of such agents with high enrichment in tumors and excellent photothermal performance remains challenging. Results: We prepared hyaluronic acid (HA)-coated Bi-doped cuprous oxide (Bi:Cu2O@HA) via a one-pot method. The HA specifically targets colon cancer tumor cells to improve the enrichment of Bi:Cu2O@HA at tumor sites, while the doped Bi both enhances the photothermal performance of the H2S-triggered Cu2O and serves as an agent for tumor imaging. The results in this work demonstrated that the Bi:Cu2O@HA nanoparticles exhibit good biocompatibility, target colon cancer tumor cells, facilitate computed tomography imaging, and enhanced H2S-responsive photothermal therapy performance, resulting in an excellent therapeutic effect in colon cancer. Conclusions: The novel Bi:Cu2O@HA nanoparticles exhibit excellent tumor targeting and photothermal therapeutic effects, which provide new strategies and insights for colon cancer therapy. Graphical

6 January 2025 in Regenerative Biomaterials
Verified
Journal Article
Open access
MLMinhao Liang
Minhao Liang
LZLei Zhou
Lei Zhou
JLJuan Li
Juan Li
BLBin Liang
Bin Liang
LZLiangyun Zhou
Liangyun Zhou
WHwei Hong
wei Hong
Postmenopausal osteoporosis (PMOP) is a predominant form of clinical osteoporosis. It has led to significant health and social burdens for older patients. Reestablishing the balance between osteogenic and osteoclastic is a crucial strategy for treating PMOP. Curcumin (Cur), a naturally derived polyphenolic substance, has gained recognition as a viable option for treating osteoporosis. Despite its potential, the clinical use of Cur is hindered by its limited bioavailability and the presence of side effects. Nanoparticles modified with aspartic acid octapeptide (ASP8) exhibit a strong affinity for bone tissue, facilitating targeted delivery. This study presents novel acid-responsive zeolite imidazolate framework-8 (ZIF) nanoparticles modified with ASP8 and loaded with Cur (Cur@ZIF@ASP8, CZA). Upon delivery by this nanoparticle drug delivery system, Cur can effectively regulate bone homeostasis, offering a potential therapeutic strategy for osteoporosis. This study demonstrated that CZA nanoparticles could successfully transport Cur to bone tissue without significant toxicity. Furthermore, nanoparticles promote bone formation and inhibit osteoclast activity. They also modify the expression of related genes and proteins, such as OCN, ALP, CTSK and MMP9. Significant evaluations utilizing microcomputed tomography, Masson’s staining, hematoxylin and eosin staining and immunofluorescence staining demonstrated that intravenous CZA administration in ovariectomized mice resulted in bone destruction while simultaneously reducing overall bone loss. In conclusion, CZA nanoparticles hold promise as a therapeutic option for osteoporosis.

19 October 2020 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
XLXiaomin Li
Xiaomin Li
JWJunyi Wang
Junyi Wang
FXFengfeng Xue
Fengfeng Xue
YWYichen Wu
Yichen Wu
HXHualong Xu
Hualong Xu
QLQiaowei Li
Qiaowei Li